Enhancing patient engagement: the influence of an in-consult patient decision aid on shared decision-making for lung tumour radiation - protocol for the randomised trial 'SDM Lung SBRT'
- Thomas Leth Fink 1,2, Torben Frøstrup Hansen 3,2, Charlotte Kristiansen 3, Torben Schjødt Hansen 3, Rune Slot Thing 3, Signe Timm 3,2, Karina Dahl Steffensen 2,4
- 1Department of Oncology, Lillebaelt Hospital-University Hospital of Southern Denmark, Vejle, Denmark thomas.leth.fink@rsyd.dk.
- 2Department of Regional Health Research, University of Southern Denmark, Vejle, Denmark.
- 3Department of Oncology, Lillebaelt Hospital-University Hospital of Southern Denmark, Vejle, Denmark.
- 4Center for Shared Decision Making, Lillebaelt Hospital-University Hospital of Southern Denmark, Vejle, Denmark.
- 0Department of Oncology, Lillebaelt Hospital-University Hospital of Southern Denmark, Vejle, Denmark thomas.leth.fink@rsyd.dk.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study introduces a patient decision aid (PtDA) to enhance shared decision-making (SDM) in lung stereotactic body radiation therapy (SBRT). Engaging patients in treatment decisions for tumors near the thoracic wall is crucial for optimizing outcomes.
Area Of Science
- Radiation Oncology
- Clinical Decision-Making
- Patient Engagement
Background
- Shared decision-making (SDM) is increasingly promoted in healthcare.
- Planning stereotactic body radiation therapy (SBRT) for lung tumors near the thoracic wall involves balancing tumor control with minimizing side effects like pain and fractures.
- Currently, radiation oncologists often unilaterally decide on SBRT doses without patient input.
Purpose Of The Study
- To introduce the protocol for the 'SDM Lung SBRT' randomized trial.
- To evaluate the effectiveness of a patient decision aid (PtDA) in promoting patient engagement during SDM for lung SBRT.
- To explore patient preferences in treatment decisions involving radiation dose escalation versus toxicity risk.
Main Methods
- A randomized trial involving patients with lung tumors ≤1 cm from the thoracic wall.
- Patients are randomized to consultations with or without a PtDA.
- Treatment options include varying radiation doses (66 Gy/3 fractions, 45 Gy/3 fractions) or no treatment. The primary outcome is patient engagement measured by the OPTION-12 score.
Main Results
- The study is designed to measure patient engagement using the OPTION-12 score.
- Secondary outcomes include patient-reported quality of life and side effects.
- Results will be disseminated through scientific meetings and peer-reviewed publications.
Conclusions
- Engaging patients in SBRT treatment decisions for lung tumors near the thoracic wall is essential.
- The PtDA aims to facilitate informed patient participation in complex treatment choices.
- This trial will provide valuable data on SDM in the context of lung SBRT.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:13
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
01:21
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

